Background The nuclear lamina is a key determinant of nuclear architecture, integrity and functionality in metazoan nuclei. Mutations in the human lamin A gene lead to highly debilitating genetic diseases termed as laminopathies. Expression of lamin A mutations or reduction in levels of endogenous A-type lamins leads to nuclear defects such as abnormal nuclear morphology and disorganization of heterochromatin. This is accompanied by increased proteasomal degradation of certain nuclear proteins such as emerin, nesprin-1α, retinoblastoma protein and heterochromatin protein 1 (HP1). However, the pathways of proteasomal degradation have not been well characterized. Methodology/Principal Findings To investigate the mechanisms underlying the degradation of HP1 proteins upon lamin misexpression, we analyzed the effects of shRNA-mediated knock-down of lamins A and C in HeLa cells. Cells with reduced levels of expression of lamins A and C exhibited proteasomal degradation of HP1α and HP1β but not HP1γ. Since specific ubiquitin ligases are upregulated in lamin A/C knock-down cells, further studies were carried out with one of these ligases, RNF123, which has a putative HP1-binding motif. Ectopic expression of GFP-tagged RNF123 directly resulted in degradation of HP1α and HP1β. Mutational analysis showed that the canonical HP1-binding pentapeptide motif PXVXL in the N-terminus of RNF123 was required for binding to HP1 proteins and targeting them for degradation. The role of endogenous RNF123 in the degradation of HP1 isoforms was confirmed by RNF123 RNAi experiments. Furthermore, FRAP analysis suggested that HP1β was displaced from chromatin in laminopathic cells. Conclusions/Significance Our data support a role for RNF123 ubiquitin ligase in the degradation of HP1α and HP1β upon lamin A/C knock-down. Hence lamin misexpression can cause degradation of mislocalized proteins involved in key nuclear processes by induction of specific components of the ubiquitin-proteasome system.
References
[1]
Broers JL, Ramaekers FC, Bonne G, Yaou RB, Hutchison CJ (2006) Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev 86: 967–1008.
Dechat T, Pfleghaar K, Sengupta K, Shimi T, Shumaker DK, et al. (2008) Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes Dev 22: 832–853.
[4]
Parnaik VK (2008) Role of nuclear lamins in nuclear organization, cellular signaling and inherited diseases. Int Rev Cell Mol Biol 266: 157–206.
[5]
Andrés V, González JM (2009) Role of A-type lamins in signaling, transcription, and chromatin organization. J Cell Biol 187: 945–957.
[6]
Liu J, Ben-Shahar TR, Riemer D, Treinin M, Spann P, et al. (2000) Essential roles for Caenorhabditis elegans lamin gene in nuclear organization, cell cycle progression, and spatial organization of nuclear pore complexes. Mol Biol Cell 11: 3937–3947.
[7]
Gurudatta BV, Shashidhara LS, Parnaik VK (2010) Lamin C and chromatin organization in Drosophila. J Genet 89: 37–49.
[8]
Nikolova V, Leimena C, McMahon AC, Tan JC, Chandar S, et al. (2004) Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. J Clin Invest 113: 357–69.
[9]
Goldman RD, Shumaker DK, Erdos MR, Eriksson M, Goldman AE, et al. (2004) Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 101: 8963–8968.
[10]
Columbaro M, Capanni C, Mattioli E, Novelli G, Parnaik VK, et al. (2005) Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment. Cell Mol Life Sci 62: 2669–2678.
[11]
Shumaker DK, Dechat T, Kohlmaier A, Adam SA, Bozovsky MR, et al. (2006) Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging. Proc Natl Acad Sci USA 103: 8703–8708.
[12]
Filesi I, Gullotta F, Lattanzi G, D’Apice MR, Capanni C, et al. (2005) Alterations of nuclear envelope and chromatin organization in mandibuloacral dysplasia, a rare form of laminopathy. Physiol Genomics 23: 150–158.
[13]
Parnaik VK, Chaturvedi P, Bh Muralikrishna (2011) Lamins, laminopathies and disease mechanisms: possible role for proteasomal degradation of key regulatory proteins. J Biosci 36: 471–479.
[14]
Johnson BR, Nitta RT, Frock R L, Mounkes L, Barbie DA, et al. (2004) A-type lamins regulate retinoblastoma protein function by promoting sub-nuclear localization and preventing proteasomal degradation. Proc Natl Acad Sci USA 101: 9677–9682.
[15]
Muchir A, Massart C, van Engelen BG, Lammens M, Bonne G, et al. (2006) Proteasome-mediated degradation of integral inner nuclear membrane protein emerin in fibroblasts lacking A-type lamins. Biochem Biophys Res Commun 351: 1011–1017.
[16]
Nitta RT, Smith CL, Kennedy BK (2007) Evidence that proteasome-dependent degradation of the retinoblastoma protein in cells lacking A-type lamins occurs independently of gankyrin and MDM2. PLoS ONE 2: e963.
[17]
Chaturvedi P, Parnaik VK (2010) Lamin A rod domain mutants target heterochromatin protein 1α and β for proteasomal degradation by activation of F-box protein, FBXW10. PLoS ONE 5: e10620.
[18]
Hiragami K, Festenstein R (2005) Heterochromatin protein 1, a pervasive controlling influence. Cell Mol Life Sci 62: 2711–2726.
[19]
Hediger F, Gasser SM (2006) Heterochromatin protein 1: don’t judge the book by its cover! Curr Opin Genet Dev. 16: 143–150.
[20]
Muralikrishna Bh, Chaturvedi P, Sinha K, Parnaik VK (2012) Lamin misexpression mediates ATR kinase degradation by activation of three distinct ubiquitin ligase systems. Mol Cell Biochem 365: 323–332.
[21]
Sullivan T, Escalante-Alcade D, Bhatt H, Anver M, Bhat N, et al. (1999) Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 147: 913–920.
[22]
Vogel MJ, Guelen L, de Wit E, Peric-Hupkes D, Lodén M, et al. (2006) Human heterochromatin proteins form large domains containing KRAB-ZNF genes. Genome Res 16: 1493–1504.
[23]
Deshaies RJ, Joazeiro CA (2009) RING domain E3 ubiquitin ligases. Annu Rev Biochem 78: 399–434.
[24]
Kamura T, Hara T, Matsumoto M, Ishida N, Okumura F, et al. (2004) Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase. Nat Cell Biol 6: 1229–1235.
[25]
Kotoshiba S, Kamura T, Hara T, Ishida N, Nakayama KI (2005) Molecular dissection of the interaction between p27 and Kip1 ubiquitylation-promoting complex, the ubiquitin ligase that regulates proteolysis of p27 in G1 phase. J Biol Chem 280: 17694–17700.
[26]
Thiru A, Nietlispach D, Mott HR, Okuwaki M, Lyon D, et al. (2004) Structural basis of HP1/PXVXL motif peptide interactions and HP1 localisation to heterochromatin. EMBO J. 23: 489–499.
[27]
Lechner MS, Schultz DC, Negorev D, Maul GG, Rauscher FJ (2005) The mammalian heterochromatin protein 1 binds diverse nuclear proteins through a common motif that targets the chromoshadow domain. Biochem Biophys Res Commun 331: 929–937.
[28]
Herold S, Hock A, Herkert B, Berns K, Mullenders J, et al. (2008) Miz1 and HectH9 regulate the stability of the checkpoint protein, TopBP1. EMBO J 27: 2851–2861.
[29]
Jia S, Kobayashi R, Grewal SI (2005) Ubiquitin ligase component Cul4 associates with Cir4 histone methyltransferase to assemble heterochromatin. Nat Cell Biol 7: 1007–1013.
[30]
Carrano AC, Eytan E, Hershko A, Pagano M (1999) SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1: 193–199.
[31]
Lu BY, Emtage PC, Duyf BJ, Hilliker AJ, Eissenberg JC (2000) Heterochromatin protein 1 is required for the normal expression of two heterochromatin genes in Drosophila. Genetics. 155(2): 699–708.
[32]
Aucott R, Bullwinkle J, Yu Y, Shi W, Billur M, et al. (2008) HP1β is required for development of the cerebral neocortex and neuromuscular junctions. J Cell Biol 183: 597–606.
[33]
Mariappan I, Parnaik VK (2005) Sequestration of pRb by cyclin D3 causes intranuclear reorganization of lamin A/C during muscle cell differentiation. Mol Biol Cell 16: 1948–1960.
[34]
Manju K, Muralikrishna Bh, Parnaik VK (2006) Expression of disease-causing lamin mutants impairs the formation of DNA repair foci. J Cell Sci 119: 2704–2714.
[35]
Schmiedeberg L, Weisshart K, Diekmann S, Meyer Zu Hoerste G, Hemmerich P (2004) High- and low-mobility populations of HP1 in heterochromatin of mammalian cells. Mol Biol Cell 15: 2819–2833.
[36]
Tripathi K, Parnaik VK (2008) Differential dynamics of splicing factor SC35 during the cell cycle. J Biosci 33: 345–354.
[37]
Phair RD, Misteli T (2000) High mobility of proteins in the mammalian cell nucleus. Nature 404: 604–609.
